China's largest beauty brand, Proya Cosmetics, has opened a European innovation centre laboratory in Paris, with skin longevity and mitochondrial health named as the first of its four core research pillars.

The Hangzhou-based company frames the site as an overseas research instrument for its "Double Ten Strategy," a plan to build what it calls a technology-driven global cosmetics platform. The lab will work on four areas: skin longevity and mitochondrial health (the study of how cellular energy production affects skin ageing), skin biomechanics and barrier resilience, formula innovation, and sustainable ingredients and related technologies.

What does the Paris lab actually do?

According to the company, the site integrates closely with Proya's Longwu R&D Center in Hangzhou and its Shanghai R&D Centre. The stated model is a global innovation network combining "local demand responsiveness + international technological synergy," with Paris acting as a hub to absorb international beauty-science insight and feed it back into domestic R&D.

That formulation deserves scrutiny. The description is directional rather than evidential; the company has not yet published research outputs, staffing numbers, or budget figures for the centre. What is documented is the opening itself and the research agenda.

Who attended the inauguration?

The ceremony drew senior figures from both the company and the French beauty establishment:

• Hou Juncheng, founder and Chairman of Proya Cosmetics
• Dr. Sun Peiwen, Chief R&D and Innovation Officer
• Dr. Lieve Declercq, Chief Scientific Advisor and VP of the Europe Innovation Centre
• Antoine Deconinck, General Manager of the European Innovation Center
• Christophe Masson, CEO of Cosmetic Valley, the French cosmetics industry cluster

Other French beauty industry leaders, international experts from academia and clinical practice, and representatives from key suppliers and partners also attended, the company said.

A forum on longevity science

To mark the opening, Proya hosted a scientific forum inside the new laboratory under the theme "Longevity Science Meets Beauty: New Frontiers in Next-Generation Cosmetics." Three international experts presented: Dr. Maria Cavinato, Prof. Philippe Humbert, and Dr. Jérôme Paris.

The choice of theme signals where the company intends to concentrate. Skin longevity, paired here with mitochondrial health, is a fast-growing claim area in cosmeceuticals, and one where substantiation standards vary widely. Proya has named the direction; the burden now sits with published data.

For dermatology observers, the significance is structural rather than clinical. A Chinese market leader placing research capability in France, adjacent to Cosmetic Valley and European academic expertise, suggests a bid for scientific credibility in Western markets, not merely manufacturing reach.

Whether the Paris lab becomes a genuine source of peer-reviewed skin biology research or a marketing-adjacent outpost will be measurable in one currency: publications. The first trials and papers from the centre, and their evidence class, will tell clinicians whether the longevity claims carry weight.